<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">740421</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2021.740421</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Uncommon Bis-Amide Matrine-type Alkaloids From <italic>Sophora alopecuroides</italic> With Anti-inflammatory Effects</article-title>
<alt-title alt-title-type="left-running-head">Luo et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Matrine-Type Alkaloids With Anti-Inflammatory Effects</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Ding</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1403436/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tu</surname>
<given-names>Zhenchao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yin</surname>
<given-names>Wenjing</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fan</surname>
<given-names>Chunlin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Nenghua</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Zhongnan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Weilong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Li</surname>
<given-names>Yaolan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/359889/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Guocai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/530704/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhang</surname>
<given-names>Yubo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1448401/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Guangdong Province Key Laboratory of Pharmacodynamic Constituents of TCM and New Drugs Research, Institute of Traditional Chinese Medicine &#x26; Natural Products, College of Pharmacy, Jinan University, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Department of Neurosurgery, The First Affiliated Hospital of Jinan University, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Guangdong Clinical Translational Center for Targeted Drug, Department of Pharmacology, School of Medicine, Jinan University, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/59958/overview">Laurent G. D&#xe9;saubry</ext-link>, INSERM U1260 Nanomedicine r&#xe9;g&#xe9;n&#xe9;ratrice (RNM), France</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/971134/overview">Gennaro Pescitelli</ext-link>, University of Pisa, Italy</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1139156/overview">Ahmed Elkamhawy</ext-link>, Mansoura University, Egypt</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yaolan Li, <email>tliyl@jnu.edu.cn</email>; Guocai Wang, <email>twangguocai@jnu.edu.cn</email>; Yubo Zhang, <email>ybzhang99@126.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Medicinal and Pharmaceutical Chemistry, a section of the journal Frontiers in Chemistry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>09</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>740421</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>07</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>01</day>
<month>09</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Luo, Tu, Yin, Fan, Chen, Wu, Ding, Li, Wang and Zhang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Luo, Tu, Yin, Fan, Chen, Wu, Ding, Li, Wang and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Four new alkaloids (1&#x2013;4) belonging to rare examples of bis-amide matrine-type were isolated from the seeds of sophora alopecuroides. Their structures including absolute configuration were determined by extensive spectroscopic analysis, electronic circular dichroism (ECD) interpretation, and X-ray diffraction crystallography. Chemically, bis-amide matrine-type alkaloids can provide new molecular template for structural modification. Compounds 3&#x2013;4 displayed obvious anti-inflammatory effects based on the inhibition of two key pro-inflammatory cytokines [tumor necrosis factor-&#x3b1; (TNF-&#x3b1;) and interleukin-6 (IL-6)] in a dose-dependent manner, with IC50 values from 35.6 to 45.8&#xa0;&#x3bc;m.</p>
</abstract>
<kwd-group>
<kwd>matrine-type alkaloids</kwd>
<kwd>water-soluble alkaloids</kwd>
<kwd>
<italic>Sophora</italic> alopecuroides</kwd>
<kwd>structure modification</kwd>
<kwd>structure elucidation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>
<italic>Sophora alopecuroides</italic> L. which belongs to the family of Leguminosae, is a salt-tolerant perennial herb plant and distributed in arid desert grassland of northwest China (<xref ref-type="bibr" rid="B14">Wang et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B5">Deng et&#x20;al., 2019</xref>). The seeds of <italic>S. alopecuroides</italic> (Chinese name: Ku-Dou-Zi) has been regarded as a well-known traditional Chinese medicine for the treatment of fever, rheumatism, bacterial infection and inflammatory diseases (<xref ref-type="bibr" rid="B9">Huang et&#x20;al., 2016</xref>). Previous phytochemical investigations on <italic>S. alopecuroides</italic> revealed alkaloids as one of principal active chemical constituents. Among them, matrine-type alkaloids exhibit diverse bioactivities such as antiviral (<xref ref-type="bibr" rid="B21">Zou et&#x20;al., 2020</xref>), anti-insect (<xref ref-type="bibr" rid="B8">Huang et&#x20;al., 2017</xref>), anti-tumor (<xref ref-type="bibr" rid="B10">Li et&#x20;al., 2020</xref>), and promising anti-inflammatory activities (<xref ref-type="bibr" rid="B9">Huang et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B10">Li et&#x20;al., 2020</xref>).</p>
<p>Chemically, matrine-type alkaloids are considered as ideal lead compounds for further structure modifications because of special chemical structure, widespread biological activities, high safety threshold, as well as available commercial sources. In order to improve the activities and amplify their applicants, many matrine-type derivatives have been synthesized and reported in the recent years (<xref ref-type="bibr" rid="B8">Huang et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B1">Cai et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B4">Cheng et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B12">Lv et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B3">Cheng et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B15">Xu et&#x20;al., 2020</xref>). Interestingly, we have noticed that almost all structural modifications were concentrated in the variations of D ring, such as introducing substituents to C-13 and C-14 sites, opening D ring, fusing D ring and further molecular simplification. However, the amide bond located at D ring is a critical part that can responsible for many biological activities according to the molecular docking analysis (<xref ref-type="bibr" rid="B13">Peng et&#x20;al., 2020</xref>). It is necessary to search more matrine-type template for the development of structural modification strategy.</p>
<p>As a part of continuous systematic search for structurally unique and biologically meaningful natural products from the <italic>sophora</italic> species (<xref ref-type="bibr" rid="B6">Fan et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B11">Luo et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B17">Zhang et&#x20;al., 2018a</xref>; <xref ref-type="bibr" rid="B18">Zhang et&#x20;al., 2018b</xref>; <xref ref-type="bibr" rid="B19">Zhang et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B20">Zhang et&#x20;al., 2017</xref>), four new matrine-type alkaloids (1&#x2013;4) were obtained and identified (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). It is worth mentioning that compounds 1&#x2013;4 are uncommon examples of bis-amide matrine with the second amide group at C-2 or C-10. To data, hundreds of matrine-type alkaloids have been reported but only few cases such as 2-oxymatrine, 10-oxy-5,6-dehydromatrine, and 10-oxysophoridine that possessed the bis-amide bond at C-2 or C-10 (<xref ref-type="bibr" rid="B19">Zhang et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B17">Zhang et&#x20;al., 2018a</xref>). Additionally, all isolates were evaluated their anti-inflammatory activities <italic>in&#x20;vitro</italic> based on production of two key pro-inflammatory cytokines (TNF-<italic>&#x3b1;</italic> and IL-6) in lipopolysaccharides (LPS)-stimulated RAW264.7 cells. Herein, the isolation, strucutre elucidation, and anti-inflammatory activites of those isolates are discussed.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Chemical structures of compounds 1&#x2013;4.</p>
</caption>
<graphic xlink:href="fchem-09-740421-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>General Experimental Procedures</title>
<p>The UV spectra, optical rotations, and IR spectra were determined on a JASCO V-550 UV/VIS spectrophotometer in MeOH solutions, an Autopol JASCO P-1020 polarimeter with concentrations unit reported in g/100&#xa0;ml, a JASCO FT/IR-480 plus FT-IR spectrometer with KBr disks and peaks reported in cm<sup>&#x2212;1</sup> (JASCO corporation, Tokyo, Japan), respectively. ECD spectrum were carried out on a JASCO J-810 spectrometer. NMR experiments including 1D and 2D spectra were run on a Bruker Avance 600 NMR (600&#xa0;MHz for <sup>1</sup>H/150&#xa0;MHz for <sup>13</sup>C) spectrometer using standard Bruker pulse sequences (Bruker-Biospin, United&#x20;States). HRESIMS data were measured from an Agilent 6210 LC/MSD Q-TOF mass instrument (Agilent Technologies, CA, United&#x20;States). Analysis and preparation of crude samples were performed on HPLC using Shimadzu 6AD series with a PDA detector (Shimadzu corporation, Tokyo, Janpan). Al<sub>2</sub>O<sub>3</sub> thin layer chromatography (TLC) analysis was done on aluminium oxide 60&#xa0;F 254 basic plates (Merck, China). Column chromatography (CC) was undertaken with D-101 macroporous resin (Diaion, Shanghai, China), simon alumina N (size 200&#x2013;300 mesh, Aldrich, China), Sephadex LH-20 (size 25&#x2013;100&#xa0;mm, Fluka, Buchs, Switzerland), CHP20P MCI gel (size 75&#x2013;150&#xa0;&#x3bc;m, Sigma-Aldrich company Ltd. China), and ODS silica gel (size 50&#xa0;mm; YMC, Tokyo, Japan).</p>
</sec>
<sec id="s2-2">
<title>Plant Material</title>
<p>The dry seeds of <italic>S. alopecuroides</italic> L. were collected from the area (GPS coordinates, 37&#xb0;98&#x2032;&#x2212;38&#xb0;22&#x2032; N, 106&#xb0;20&#x2032;&#x2212;106&#xb0;66&#x2032; E) of Wuzhong City, Ningxia Hui Autonomous Region, People&#x2019;s Republic of China on August 2014. A voucher specimen (accession no. SA-2014&#x2013;08&#x2013;28) was authenticated by Prof. Guang-Xiong Zhou (Jinan University) and available for inspection at the Institute of Traditional Chinese Medicine and Natural Products, Jinan University, Guangzhou, P. R. China.</p>
</sec>
<sec id="s2-3">
<title>Extraction and Isolation</title>
<p>The dry seeds of <italic>S. alopecuroides</italic> (&#x223c;30&#xa0;kg) were powdered and percolated thrice with 95% EtOH and the pooled extracts were concentrated to give the total extract (&#x223c;1.9&#xa0;kg). The crude residue was suspended with 0.1&#xa0;M aqueous HCl until acidified to pH 2&#x2013;3. After removal of the nonalkaloid components with CHCl<sub>3</sub>, the remaining acidic solvent was subsequently adjusted to pH 9&#x2013;10 basified with saturated NH<sub>3</sub> solution in water and partitioned with CHCl<sub>3</sub> five times to yield total alkaloids (0.8&#xa0;kg, extraction coefficient: 2.67%). The CHCl<sub>3</sub> layer alkaloid was fractionated via D&#x2212;101 macroporous resin CC eluting with EtOH&#x2212;H<sub>2</sub>O (from 10:90 to 95:5, <italic>v</italic>:<italic>v</italic>) to yield five major fractions (Fr.1&#x2212;5), based on the ratio of ethanol and water. Fr. 1 was dissolved in deionized water, and extracted twice with ethyl acetate (EtOAc) to remove the fat-soluble part. Subsequently, Fr. 1A (50.1&#xa0;g) was subjected to Al<sub>2</sub>O<sub>3</sub>-based chromatography column (200&#x2013;300 mesh) eluted with CH<sub>2</sub>Cl<sub>2</sub> containing increasing amount of MeOH (100:0 to 0:100, <italic>v/v</italic>) added 1% Et<sub>2</sub>NH to produce seven portions (Fr.1Aa&#x2013;Fr.1Ag), based on Al<sub>2</sub>O<sub>3</sub>-based TLC analysis. Fr.1Af (18.0&#xa0;g) was separated on a RP-MCI column chromatography with a gradient of CH<sub>3</sub>OH/H<sub>2</sub>O/Et<sub>2</sub>NH (5:95:0.01 to 60:40:0.01) to generated five fractions (Fr.1Af.1&#x2212;5). Fr.1Af.1 was applied to a Sephadex LH&#x2212;20 column (CH<sub>3</sub>OH/H<sub>2</sub>O, 2:1, <italic>v/v</italic>) to obtain three subfractions (Fr.1Af.1.1&#x2013;Fr.1Af.1.3). Fr.1Af.1.2 was purified by ODS CC (CH<sub>3</sub>OH/H<sub>2</sub>O, 5:95&#x2192;40:60, <italic>v/v</italic>) and further separated by preparative HPLC with CH<sub>3</sub>CN/H<sub>2</sub>O/Et<sub>2</sub>NH (15:85:0.01, <italic>v/v/v</italic>) to give compounds 1 (19.4 mg, <italic>t</italic>
<sub>R</sub> &#x3d; 21.4&#xa0;min), 2 (11.1&#xa0;mg, <italic>t</italic>
<sub>R</sub> &#x3d; 23.8&#xa0;min), 3 (23.2&#xa0;mg, <italic>t</italic>
<sub>R</sub> &#x3d; 17.8&#xa0;min), 4 (24.9&#xa0;mg, <italic>t</italic>
<sub>R</sub> &#x3d; 16.9&#xa0;min).</p>
<p>(&#x2b;)-10-Oxy-9<italic>&#x3b2;</italic>-hydroxymatrine (1): colorless crystals in MeOH; mp 147&#x2013;148&#xb0;C [<italic>&#x3b1;</italic>]<sub>25</sub>
<sup>D</sup> &#x2b;84.0 (<italic>c</italic> 0.01, CH<sub>3</sub>OH); UV (CH<sub>3</sub>OH) <italic>&#x3bb;</italic>
<sub>max</sub> (log <italic>&#x3b5;</italic>) 205 (3.52)&#xa0;nm; IR (KBr) <italic>&#x3bd;</italic>
<sub>max</sub> 3,252, 2,927, 2,867, 1,627, 1,597, 1,408, 1,058&#xa0;cm<sup>&#x2212;1</sup>; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref ref-type="table" rid="T1">Table&#x20;1</xref>; HRESIMS <italic>m/z</italic> 279.1698 [M &#x2b; H]<sup>&#x2b;</sup> (calcd for C<sub>15</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub>, 279.1703).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>
<sup>1</sup>H (600&#xa0;MHz) and<sup>13</sup>C NMR (150&#xa0;MHz) data of compounds one to four in CDCl<sub>3</sub> (<italic>&#x3b4;</italic> in ppm, <italic>J</italic> in Hz)<xref ref-type="table-fn" rid="Tfn1">
<sup>a</sup>
</xref>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="left">No</th>
<th colspan="2" align="center">1</th>
<th colspan="2" align="center">2</th>
<th colspan="2" align="center">3</th>
<th colspan="2" align="center">4</th>
</tr>
<tr>
<th align="center">
<italic>&#x3b4;</italic>
<sub>C</sub>
</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>H</sub>
</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>C</sub>
</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>H</sub>
</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>C</sub>
</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>H</sub>
</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>C</sub>
</th>
<th align="center">
<italic>&#x3b4;</italic>
<sub>H</sub>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">2</td>
<td align="center">42.3</td>
<td align="center">a 4.55 dd (11.6, 2.5); b 2.73</td>
<td align="center">44.1</td>
<td align="center">a 4.69 dd (13.2, 4.4); b 2.59 td (13.2, 2.9)</td>
<td align="center">167.8</td>
<td align="left"/>
<td align="center">39.5</td>
<td align="center">a 3.76; b 3.76</td>
</tr>
<tr>
<td align="left">3</td>
<td align="center">19.7</td>
<td align="center">a 1.66; b 1.66</td>
<td align="center">25.0</td>
<td align="center">a 1.79; b 1.53</td>
<td align="center">27.8</td>
<td align="center">a 2.92&#xa0;m; b 2.54</td>
<td align="center">20.4</td>
<td align="center">a 1.93; b 1.62</td>
</tr>
<tr>
<td align="left">4</td>
<td align="center">26.5</td>
<td align="center">a 1.79; b 1.67</td>
<td align="center">29.8</td>
<td align="center">a 1.94; b 1.29</td>
<td align="center">29.7</td>
<td align="center">a 1.96&#xa0;m; b 1.76</td>
<td align="center">32.0</td>
<td align="center">a 1.88; b 1.84</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">34.4</td>
<td align="center">1.94</td>
<td align="center">35.8</td>
<td align="center">1.83</td>
<td align="center">65.1</td>
<td align="left"/>
<td align="center">68.1</td>
<td align="left"/>
</tr>
<tr>
<td align="left">6</td>
<td align="center">57.0</td>
<td align="center">3.54&#xa0;days (3.4)</td>
<td align="center">59.6</td>
<td align="center">3.27 dd (11.0, 9.0)</td>
<td align="center">133.2</td>
<td align="left"/>
<td align="center">134.9</td>
<td align="left"/>
</tr>
<tr>
<td align="left">7</td>
<td align="center">40.7</td>
<td align="center">1.83</td>
<td align="center">36.1</td>
<td align="center">2.34</td>
<td align="center">113.7</td>
<td align="left"/>
<td align="center">117.2</td>
<td align="left"/>
</tr>
<tr>
<td align="left">8</td>
<td align="center">29.3</td>
<td align="center">a 2.18; b 1.95</td>
<td align="center">28.4</td>
<td align="center">a 2.13; b 1.87</td>
<td align="center">24.1</td>
<td align="center">a 2.20&#xa0;m; b 1.87 dd (17.0, 4.8)</td>
<td align="center">21.3</td>
<td align="center">a 2.39; b 2.09</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">66.8</td>
<td align="center">4.18&#xa0;days (5.9)</td>
<td align="center">64.3</td>
<td align="center">4.01 dd (10.4, 4.2)</td>
<td align="center">21.3</td>
<td align="center">a 2.00; b 1.63</td>
<td align="center">32.4</td>
<td align="center">a 2.55; b 2.48</td>
</tr>
<tr>
<td align="left">10</td>
<td align="center">172.8</td>
<td align="left"/>
<td align="center">170.5</td>
<td align="left"/>
<td align="center">39.7</td>
<td align="center">a 4.71&#xa0;days (13.2); b 2.78&#xa0;t (13.2)</td>
<td align="center">168.9</td>
<td align="left"/>
</tr>
<tr>
<td align="left">11</td>
<td align="center">54.0</td>
<td align="center">3.77&#xa0;m</td>
<td align="center">53.3</td>
<td align="center">3.67&#xa0;m</td>
<td align="center">58.6</td>
<td align="center">3.92 dd (11.3, 3.8)</td>
<td align="center">56.8</td>
<td align="center">4.12 (11.3, 4.1)</td>
</tr>
<tr>
<td align="left">12</td>
<td align="center">27.4</td>
<td align="center">2.41&#xa0;m; 1.45</td>
<td align="center">27.7</td>
<td align="center">2.21; 1.43</td>
<td align="center">28.3</td>
<td align="center">a 2.33&#xa0;days (13.5); b 1.49&#xa0;m</td>
<td align="center">26.8</td>
<td align="center">a 2.22; b 1.35</td>
</tr>
<tr>
<td align="left">13</td>
<td align="center">19.0</td>
<td align="center">a 1.81; b 1.66</td>
<td align="center">19.1</td>
<td align="center">a 1.93; b 1.67</td>
<td align="center">20.0</td>
<td align="center">a 1.97; b 1.75&#xa0;m</td>
<td align="center">19.4</td>
<td align="center">a 1.88; b 1.73</td>
</tr>
<tr>
<td align="left">14</td>
<td align="center">32.9</td>
<td align="center">a 2.44; b 2.26</td>
<td align="center">32.3</td>
<td align="center">a 2.46&#xa0;m; b 2.34</td>
<td align="center">32.2</td>
<td align="center">a 2.55&#xa0;m; b 2.43</td>
<td align="center">31.2</td>
<td align="center">a 2.38; b 2.32</td>
</tr>
<tr>
<td align="left">17</td>
<td align="center">169.7</td>
<td align="center">
<italic>&#x3b1;</italic> 4.46 dd (13.2, 4.1); <italic>&#x3b2;</italic> 2.71&#xa0;t (13.2)</td>
<td align="center">170.2</td>
<td align="center">&#x3b1; 3.65&#xa0;m; &#x3b2; 3.14&#xa0;t (13.2)</td>
<td align="center">170.7</td>
<td align="center">
<italic>&#x3b1;</italic> 4.81&#xa0;days (13.2); <italic>&#x3b2;</italic> 2.67&#xa0;days (13.2)</td>
<td align="center">170.0</td>
<td align="center">
<italic>&#x3b1;</italic> 4.63&#xa0;days (13.2); <italic>&#x3b2;</italic> 2.90&#xa0;days (13.2)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>a</label>
<p>Overlapped signals were reported without designating multiplicity.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>(&#x2212;)-10-Oxy-9<italic>&#x3b1;</italic>-hydroxysophoridine (2): pale yellow oil in MeOH [<italic>&#x3b1;</italic>]<sub>25</sub>
<sup>D</sup> &#x2212;29.2 (<italic>c</italic> 0.01, CH<sub>3</sub>OH); UV (CH<sub>3</sub>OH) <italic>&#x3bb;</italic>
<sub>max</sub> (log <italic>&#x3b5;</italic>) 206 (3.33)&#xa0;nm; ECD (CH<sub>3</sub>OH) <italic>&#x3bb;</italic>
<sub>max</sub> (&#x394;<italic>&#x3b5;</italic>) 228 (&#x2b;1.9)&#xa0;nm; IR (KBr) <italic>&#x3bd;</italic>
<sub>max</sub> 3,412, 3,256, 2,932, 2,867, 1,625, 1,603, 1,409, and 1,186&#xa0;cm<sup>&#x2212;1</sup>; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref ref-type="table" rid="T1">Table&#x20;1</xref>; HRESIMS <italic>m/z</italic> 279.1702 [M &#x2b; H]<sup>&#x2b;</sup> (calcd for C<sub>15</sub>H<sub>23</sub>N<sub>2</sub>O<sub>2</sub>, 279.1703).</p>
<p>(&#x2212;)-2-Oxy-5-hydroxy-6,7-dehydromatrine (3): colorless block crystals in MeOH; mp 135&#x2013;136&#xb0;C [<italic>&#x3b1;</italic>]<sub>25</sub>
<sup>D</sup> &#x2212;8.9 (<italic>c</italic> 0.01, CH<sub>3</sub>OH); UV (CH<sub>3</sub>OH) <italic>&#x3bb;</italic>
<sub>max</sub> (log <italic>&#x3b5;</italic>) 201 (4.08), 242 (3.11)&#xa0;nm; IR (KBr) <italic>&#x3bd;</italic>
<sub>max</sub> 3,408, 2,925, 2,765, 1,626, 1,459, and 1,098&#xa0;cm<sup>&#x2212;1</sup>; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref ref-type="table" rid="T1">Table&#x20;1</xref>; HRESIMS <italic>m/z</italic> 277.1541 [M &#x2b; H]<sup>&#x2b;</sup> (calcd for C<sub>15</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>, 277.1547).</p>
<p>(&#x2212;)-10-Oxy-5-hydroxy-6,7-dehydromatrine (4): pale yellow oil in MeOH [<italic>&#x3b1;</italic>]<sub>25</sub>
<sup>D</sup> &#x2212;12.2 (<italic>c</italic> 0.01, CH<sub>3</sub>OH); UV (CH<sub>3</sub>OH) <italic>&#x3bb;</italic>
<sub>max</sub> (log <italic>&#x3b5;</italic>) 206 (3.25) nm; ECD (CH<sub>3</sub>OH) <italic>&#x3bb;</italic>
<sub>max</sub> (&#x394;<italic>&#x3b5;</italic>) 209 (&#x2212;1.9), 228 (&#x2b;2.5), 257 (&#x2212;4.8) nm; IR (KBr) <italic>&#x3bd;</italic>
<sub>max</sub> 3,408, 2,933, 2,803, 1,623, 1,441, 1,193&#xa0;cm<sup>&#x2212;1</sup>; <sup>1</sup>H and <sup>13</sup>C NMR data, see <xref ref-type="table" rid="T1">Table&#x20;1</xref>; HRESIMS <italic>m/z</italic> 277.1546 [M &#x2b; H]<sup>&#x2b;</sup> (calcd for C<sub>15</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>, 277.1547).</p>
</sec>
<sec id="s2-4">
<title>Single X-Ray Diffraction Data Analysis</title>
<p>The single-crystal X-ray diffraction data of one and three were acquired on an Agilent diffractometer with Cu K<italic>&#x3b1;</italic> radiation. The structures were solved by the SHELXT structure solution program and refined with full-matrix least-squares minimization on <italic>F</italic>
<sup>2</sup> using SHELXL via OLEX2 software package. Crystallographic data for one and three have been deposited in the Cambridge Crystallographic Data Centre (free of charge at <ext-link ext-link-type="uri" xlink:href="https://www.ccdc.cam.ac.uk/">https://www.ccdc.cam.ac.uk/</ext-link>) under deposition numbers CCDC are 2055031 and 2095514, respectively.</p>
<p>Crystal Data for (&#x2212;)-10-oxy-9<italic>&#x3b2;</italic>-hydroxymatrine (1): C<sub>15</sub>H<sub>24</sub>N<sub>2</sub>O<sub>4</sub> (<italic>M</italic>&#x20;&#x3d; 296.36&#xa0;g/mol): orthorhombic, space group <italic>P2</italic>
<sub>
<italic>1</italic>
</sub>
<italic>2</italic>
<sub>
<italic>1</italic>
</sub>
<italic>2</italic>
<sub>
<italic>1</italic>
</sub> (no. 19), <italic>a</italic>&#x20;&#x3d; 8.4437 (2) &#xc5;, <italic>b</italic>&#x20;&#x3d; 10.5310 (3) &#xc5;, <italic>c</italic>&#x20;&#x3d; 33.5834 (7) &#xc5;, <italic>V</italic>&#x20;&#x3d; 2,986.26 (13) &#xc5;<sup>3</sup>, <italic>Z</italic>&#x20;&#x3d; 8, <italic>T</italic>&#x20;&#x3d; 149.99 (10) K, <italic>&#x3bc;</italic>(Cu K<italic>&#x3b1;</italic>)&#x20;&#x3d;&#x20;0.784&#xa0;mm<sup>&#x2212;1</sup>, <italic>Dcalc</italic> &#x3d; 1.318&#xa0;g/cm<sup>3</sup>, 13,927 reflections measured (5.262&#xb0; &#x2264; 2<italic>&#x398;</italic> &#x2264; 147.692&#xb0;), 5,895 unique (<italic>R</italic>
<sub>int</sub>&#x20;&#x3d;&#x20;0.0312, <italic>R</italic>
<sub>
<italic>s</italic>igma</sub> &#x3d; 0.0387) which were used in all calculations. The final <italic>R</italic>
<sub>1</sub> was 0.0385 (<italic>I</italic>&#x20;&#x3e; 2<italic>&#x3c3;</italic>(<italic>I</italic>)) and <italic>wR</italic>
<sub>2</sub> was 0.0912 (all data). Flack parameter &#x2212;0.09 (10). Hooft parameter: &#x2212;0.06 (10). CCDC number is 2055031.</p>
<p>Crystal Data for (&#x2212;)-2-oxy-5-hydroxy-6,7-dehydromatrine (3): C<sub>15</sub>H<sub>22</sub>N<sub>2</sub>O<sub>4</sub> (<italic>M</italic>&#x20;&#x3d; 294.34&#xa0;g/mol): orthorhombic, space group P2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> (no. 19), <italic>a</italic>&#x20;&#x3d; 7.41520 (10) &#xc5;, <italic>b</italic>&#x20;&#x3d; 10.77360 (10) &#xc5;, <italic>c</italic>&#x20;&#x3d; 17.6626 (2) &#xc5;, <italic>V</italic>&#x20;&#x3d; 1,411.04 (3) &#xc5;<sup>3</sup>, <italic>Z</italic>&#x20;&#x3d; 4, <italic>T</italic>&#x20;&#x3d; 150.00 (10) K, &#x3bc;(CuK&#x3b1;) &#x3d; 0.829&#xa0;mm<sup>&#x2212;1</sup>, <italic>Dcalc</italic> &#x3d; 1.386&#xa0;g/cm<sup>3</sup>, 9,266 reflections measured (9.616&#xb0; &#x2264; 2<italic>&#x398;</italic> &#x2264; 147.622&#xb0;), 2,781 unique (<italic>R</italic>
<sub>int</sub> &#x3d; 0.0197, R<sub>sigma</sub> &#x3d; 0.0155) which were used in all calculations. The final <italic>R</italic>
<sub>1</sub> was 0.0285 (I &#x3e; 2&#x3c3;(I)) and <italic>wR</italic>
<sub>2</sub> was 0.0714 (all data). Flack parameter &#x2212;0.01 (6). Hooft parameter: &#x2212;0.05 (5). CCDC number is 2095514.</p>
</sec>
<sec id="s2-5">
<title>Electronic Circular Dichroism Calculations</title>
<p>Conformational analysis was initially performed using sybyl-X-2.1.1 program. Conformers occurring within a 10&#xa0;kcal/mol energy window from the global minimum were chosen for geometry optimization and energy calculation using DFT with the B3LYP functional and the 6&#x2013;311&#x2b;&#x2b;G (d,p) basis set with the Gaussian09 program. Calculated results were completed using TD-DFT with the CPCM model in MeOH based on the optimized geometries. Finally, the Boltzmann-averaged ECD spectra of the two compounds were obtained and visualized with <italic>SpecDis</italic> 1.61 and drawn using the Origin Pro nine program. The half bandwidth (<italic>&#x3c3;</italic>) and UV correction values applied in <italic>SpecDis</italic> for the final calculated ECD spectra are 0.30&#xa0;eV and &#x2212;5&#xa0;nm, 0.30&#xa0;eV and &#x2212;6&#xa0;nm for compounds 2 and 4, respectively, which are within the reasonable range. Their optimized conformation geometries, thermodynamic parameters, and populations of all conformations (2 and 4) are provided in supporting information.</p>
</sec>
<sec id="s2-6">
<title>
<italic>In vitro</italic> Cytotoxicity Assay</title>
<p>The cytotoxicity of those isolated alkaloids on RAW 264.7 cells were evaluated by <italic>3-</italic>(<italic>4,5-</italic>dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT) assay. Various concentrations of test alkaloids were used to treat the cells by the methods that published previously (<xref ref-type="bibr" rid="B7">He et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B16">Zhang et&#x20;al., 2021</xref>).</p>
</sec>
<sec id="s2-7">
<title>
<italic>In vitro</italic> Anti-inflammatory Assay</title>
<p>The anti-inflammatory activities of 1&#x2013;4 on LPS-stimulated TNF-<italic>&#x3b1;</italic> and IL-6 expression in RAW 264.7 cells were assessed using enzyme-linked immunosorbent assay (ELISA) as published previously (<xref ref-type="bibr" rid="B7">He et&#x20;al., 2019</xref>). Dexamethasone and the medium without LPS were selected as the positive or negative control&#x20;group.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussion</title>
<p>Compound 1 was isolated as colorless block crystals from CH<sub>3</sub>OH, mp 147&#x2013;148&#xb0;C [<italic>&#x3b1;</italic>]<sub>25</sub>
<sup>D</sup> &#x2b;84.0 (<italic>c</italic> 0.01, CH<sub>3</sub>OH). The molecular formula was deduced to be C<sub>15</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub> on the basis of the HRESIMS protonated molecular ion peak [M &#x2b; H]<sup>&#x208a;</sup> at <italic>m/z</italic> 278.1630, suggesting six indices of hydrogen deficiency. The UV spectrum showed maximum absorption at 206&#xa0;nm was typical for non-conjugated amide of matrine-type backbone. The IR spectrum displayed a hydroxy group (3,202&#xa0;cm<sup>&#x2212;1</sup>) and two lactam functionalities (1,627 and 1,597&#xa0;cm<sup>&#x2212;1</sup>). The <sup>1</sup>H NMR spectrum (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) exhibited signals for [<italic>&#x3b4;</italic>
<sub>H</sub> 4.70 dd (<italic>J</italic>&#x20;&#x3d; 13.2, 4.6&#xa0;Hz), 2.69&#xa0;m] and [<italic>&#x3b4;</italic>
<sub>H</sub> 4.53&#xa0;days (<italic>J</italic>&#x20;&#x3d; 13.0&#xa0;Hz), 2.66&#xa0;m], ascribed to two sets diagnostic methylene protons adjacent to N-atom of amide bond. The <sup>13</sup>C NMR spectrum (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) revealed 15 carbon resonances categorized by DEPT experiments as two carbonyls (<italic>&#x3b4;</italic>
<sub>C</sub> 172.4 and 170.3), five methines (<italic>&#x3b4;</italic>
<sub>C</sub> 74.5, 54.6, 54.3, 42.0, and 31.5), and eight methylenes (<italic>&#x3b4;</italic>
<sub>C</sub> 46.7, 32.4, 32.1, 28.4, 27.9, 25.3, 20.0, 18.9). The above spectroscopic data as well as biogenetic considerations indicated that compound 1 was a derivative of matrine (<xref ref-type="bibr" rid="B18">Zhang et&#x20;al., 2018b</xref>).</p>
<p>The planar structure and relative configuration of one was ascertained by comprehensive analysis of 2D NMR experiment (including <sup>1</sup>H&#x2013;<sup>1</sup>H COSY, HSQC, HMBC, and NOESY spectra). The characteristic HMBC correlations from H<sub>2</sub>-17 to C-4/C-5/C-6/C-11/C-17, from H-6 to C-2/C-5/C-7/C-10/C-11, from H<sub>2</sub>-8 to C-6/C-7/C-9/C-10/C-11, and from H-9 to C-7/C-8/C-10, together with <sup>1</sup>H&#x2212;<sup>1</sup>H COSY correlations of H-6/H-7/H-8/H-9 in B ring (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>), implied one more amide bond occurring at C-10 and a hydroxy group locating on C-9 of matrine-based skeleton. Furthermore, the coupling constant between H-9 and H<sub>2</sub>-8 (<sup>3</sup>
<italic>J</italic>&#x20;&#x3d; 5.6&#xa0;Hz) suggested H-9 occupied the equatorial position (<italic>&#x3b1;</italic>) in six-member ring, supported by the absence of H-9/H-11&#x20;cross-peak signal in the NOESY spectrum. Finally, the absolute configuration of (5<italic>S</italic>,6<italic>S</italic>,7<italic>,9</italic>,11<italic>R</italic>)-1 was unequivocally established by a single crystal X-ray diffraction (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>) using Cu K<italic>&#x3b1;</italic> radiation [Flack parameter: 0.09 (13)]. Thus, the structure of one was deduced as shown in <xref ref-type="fig" rid="F1">Figure&#x20;1</xref>, and named as (&#x2b;)-10-oxy-9<italic>&#x3b2;</italic>-hydroxymatrine.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Key <sup>1</sup>H&#x2212;<sup>1</sup>H COSY and HMBC correlations of 1&#x2013;4.</p>
</caption>
<graphic xlink:href="fchem-09-740421-g002.tif"/>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>X-ray ORTEP drawings of 1&#x20;<bold>(A)</bold> and 3&#x20;<bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fchem-09-740421-g003.tif"/>
</fig>
<p>Compound 2 [<italic>&#x3b1;</italic>]<sub>25</sub>
<sup>D</sup> &#x2212;29.2 (<italic>c</italic> 0.01, CH<sub>3</sub>OH), possessed a molecular formula of C<sub>15</sub>H<sub>22</sub>N<sub>2</sub>O<sub>3</sub> (calcd for C<sub>15</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub>, 279.1703) via the HRESIMS ion peak at <italic>m/z</italic> 279.1704 [M &#x2b; H]<sup>&#x2b;</sup> and <sup>13</sup>C NMR data. Its spectroscopic values showed that two is structurally similar to sophoridine (<xref ref-type="bibr" rid="B17">Zhang et&#x20;al., 2018a</xref>), while the obviously differences were that an additional amide carbon (<italic>&#x3b4;</italic>
<sub>C</sub> 170.5) and a more <italic>O</italic>-bearing methine [<italic>&#x3b4;</italic>
<sub>C</sub> 64.3, <italic>&#x3b4;</italic>
<sub>H</sub> 4.01 dd (<italic>J</italic>&#x20;&#x3d; 10.4, 4.2&#xa0;Hz)] are observed. The key HMBC cross-peaks of H<sub>2</sub>-8 to C-6/C-7/C-9/C-10/C-11 and H-6 to C-2/C-4/C-8/C-10, together with sequential COSY correlations of H-6/H-7/H<sub>2</sub>-8/H-9 in B ring (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>) lead to the full structural assignment of 2, as shown in <xref ref-type="fig" rid="F1">Figure&#x20;1</xref>. The configuration of OH-9 was deduced as equatorial orientation (<italic>&#x3b1;</italic>), which was determined by the large coupling constant of H-8&#x3b1;/H-9 (<italic>J</italic>
<sub>H-9/H-8<italic>&#x3b1;</italic>
</sub> &#x3d; 10.4&#xa0;Hz) and NOE cross-peaks (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>) of H-9 (<italic>&#x3b4;</italic>
<sub>H</sub> 4.01)/H-8a (<italic>&#x3b4;</italic>
<sub>H</sub> 2.13)/H-11 (<italic>&#x3b4;</italic>
<sub>H</sub> 3.67). Consequently, the absolute structure of two was corroborated by comparing the experiment and calculated CD curve (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). Compound 2 was thereby deduced and named as (&#x2212;)-10-oxy-9<italic>&#x3b1;</italic>-hydroxysophridine.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Key NOESY correlations of 2&#x20;<bold>(A)</bold> and 4&#x20;<bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fchem-09-740421-g004.tif"/>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Experimental ECD and calculated spectra of 2 and 4 at the B3LYP/6&#x2013;31&#x2b;G (d) level [2: &#x3c3; &#x3d; 0.30&#xa0;eV, UV shift &#x3d; &#x2212;5&#xa0;nm; 4: &#x3c3; &#x3d; 0.30&#xa0;eV, UV shift &#x3d; &#x2212;6&#xa0;nm].</p>
</caption>
<graphic xlink:href="fchem-09-740421-g005.tif"/>
</fig>
<p>Compound 3, colorless block crystals, showed an [M &#x2b; H]<sup>&#x2b;</sup> ion peak at <italic>m/z</italic> 277.1541 (calcd for C<sub>15</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>, 401.1571) in the HRESIMS spectrum, consistent with the molecular formula of C<sub>15</sub>H<sub>20</sub>N<sub>2</sub>O<sub>3</sub>. The <sup>1</sup>H and <sup>13</sup>C NMR data of 3 (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) were similar to those of 5-hydroxy-6,7-dehydro-matrine (<xref ref-type="bibr" rid="B18">Zhang et&#x20;al., 2018b</xref>). The most notable difference was that the methylene at C-10 was replaced by another lactam group (<italic>&#x3b4;</italic>
<sub>C</sub> 172.8), which was verified by the key <sup>1</sup>H&#x2013;<sup>1</sup>H COSY correlation of H-2/H-3, and HMBC cross-peaks from H<sub>2</sub>-3 to C-2/C-4, from H<sub>2</sub>-10 to C-2/C-6/C-8, and from H<sub>2</sub>-17 to C-4/C-5/C-6/C-11/C-17 (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>). Moreover, the planar structure and absolute configuration of three were determined by X-ray crystallography (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>) with an excellent Flack parameter [&#x2212;0.01 (6)]. Hence, the complete structure of three was established and named as (&#x2212;)-2-oxy-5-hydroxy-6,7-dehydromatrine.</p>
<p>Compound 4 [<italic>&#x3b1;</italic>]<sub>25</sub>
<sup>D</sup> &#x2212;12.2 (<italic>c</italic> 0.01, CH<sub>3</sub>OH), was obtained simultaneously with three in the same preparation liquid phase condition. Comprehensive analysis of its spectroscopic data indicated that four possessed the same molecular formula and almost identical 1D NMR resonances (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) as that of 3, except for the second amide group exchanged from A ring to B ring. In the 2D NMR spectra of 4, the <sup>1</sup>H&#x2013;<sup>1</sup>H COSY correlations of H<sub>2</sub>-2/H<sub>2</sub>-3/H<sub>2</sub>-4 and H<sub>2</sub>-8/H<sub>2</sub>-9, as well as HMBCs from H<sub>2</sub>-2 to C-10, and from H<sub>2</sub>-8 to C-6/C-7/C-9 suggested the second amide group is located on B ring (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>). Additionally, good consistency between the experimental CD curve and calculated ECD curve (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>) allowed the assignment of (5<italic>R</italic>,11<italic>R</italic>) absolute configuration. Thus, compound 4 was elucidated and named as (&#x2212;)-10-oxy-5-hydroxy-6,7-dehydromatrine.</p>
<p>At present, the structural modifications of matrine-type alkaloids have mainly focused on the variations of D ring due to the amide group at C-15 is an active reaction site. (<xref ref-type="bibr" rid="B1">Cai et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B2">Cai et&#x20;al., 2020</xref>). Compounds 1&#x2013;4 possessing rare bis-amide matrine-type motif could provide new molecular template and ideas for synthetic chemists. For example, new derivatives could be designed by the introduction of a protecting group on the D ring and subsequent structural modification via the second amide bond at C-2 or C-10 position on the A or B ring. So that the key part of D ring responsible for biological activity can be retained, and some unexpected good results may emerge.</p>
<p>IL-6 and TNF-&#x3b1; are essential mediators in inflammation processes. Owing to the extracts of <italic>S. alopecuroides</italic> possessing remarkable clinical effects on various kinds of inflammation, all isolated alkaloids (1&#x2013;4) were evaluated for their LPS-stimulated TNF-<italic>&#x3b1;</italic> and IL-6 production in RAW 264.7 cells using ELISA. Firstly, a MTT cytotoxicity assay was used to examine the cell viability of murine RAW 264.7 cells. The results displayed that all alkaloids at the concentration ranges from 3.125 to 50&#xa0;&#x3bc;M were non-toxic on RAW 264.7 cells after 24&#xa0;h treatment. Therefore, the tested alkaloids were applied to those concentration range to perform the next experiment. The production of IL-6 and TNF-&#x3b1; in the culture medium of the LPS-treated group both increased significantly (<italic>p</italic>&#x20;&#x3c; 0.001) in comparison with the control group after 24&#xa0;h. However, co-incubation with compounds 3&#x2013;4 suppressed the secretion of IL-6 and TNF-&#x3b1; in a dose-dependent manner, suggesting that compounds 3&#x2013;4 are inhibitor of the initial phase of the inflammatory cascade initiated by LPS stimulation. As shown in <xref ref-type="table" rid="T2">Table&#x20;2</xref>, compounds 3&#x2013;4 can inhibit the expression of those two pro-inflammatory mediator secretions (TNF-&#x3b1; and IL-6) with IC<sub>50</sub> values from 35.6 to 45.8&#xa0;&#x3bc;m, while compounds 1&#x2013;2 were inactive. In light of the structures and the anti-inflammatory activity, the existence of unsaturated double bond of &#x394;<sup>6(7)</sup> may favor this inhibitory effect.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Inhibitory activity of compounds 1&#x2013;4 against TNF-<italic>&#x3b1;</italic> and IL-6 production in RAW 264.7&#x20;cells.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Group<xref ref-type="table-fn" rid="Tfn2">
<sup>a</sup>
</xref>
</th>
<th colspan="2" align="left">IC<sub>50</sub> (<italic>&#x3bc;</italic>M)</th>
</tr>
<tr>
<th align="left"/>
<th align="left">TNF-<italic>&#x3b1;</italic>
</th>
<th align="left">IL-6</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">
<bold>1</bold>
</td>
<td align="left">&#x3e;50</td>
<td align="left">&#x3e;50</td>
</tr>
<tr>
<td align="left">
<bold>2</bold>
</td>
<td align="left">&#x3e;50</td>
<td align="left">&#x3e;50</td>
</tr>
<tr>
<td align="left">
<bold>3</bold>
</td>
<td align="left">35.6&#x20;&#xb1; 0.9</td>
<td align="left">41.2&#x20;&#xb1; 1.3</td>
</tr>
<tr>
<td align="left">
<bold>4</bold>
</td>
<td align="left">45.8&#x20;&#xb1; 1.9</td>
<td align="left">&#x3e;50&#x20;&#xb1; 0.6</td>
</tr>
<tr>
<td align="left">Dex<xref ref-type="table-fn" rid="Tfn3">
<sup>b</sup>
</xref>
</td>
<td align="left">8.8&#x20;&#xb1; 1.3</td>
<td align="left">7.2&#x20;&#xb1; 0.5</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn2">
<label>a</label>
<p>Results were expressed as means&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 3).</p>
</fn>
<fn id="Tfn3">
<label>b</label>
<p>Dex (dexamethasone) was select as positive control.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec sec-type="conclusions" id="s4">
<title>Conclusions</title>
<p>The systematic investigation of the seeds of <italic>S. alopecuroides</italic> led to the isolation of four uncommon bis-amide matrine-type alkaloids. Their special chemical structure can provide a new perspective for developing novel modificatory strategies based on A or B ring. The biological assay revealed two new compounds displayed obvious anti-inflammatory activity. This study not only enriched the structural diversity of matrine-type alkaloids, but also provided an attractive molecular candidate for pharmaceutical chemists.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s10">Supplementary Material</xref>.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>DL performed the extract, isolation, and structural elucidation of all chemical structures, and wrote the preliminary manuscript. ZT and WY contributed to the pharmacological assay. CF, NC, and ZW assisted in acquiring the experimental data. YZ, GW, and YL supervised and guided all experiments, rewrote and reviewed the manuscript. All authors have read and approved the published version of manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This project was supported financially by grants from the National Natural Science Foundation of China (nos. 81803376, 82074116, 81973190), the Guangdong Basic and Applied Basic Research Foundation (no. 2020B1515020033), the Natural Science Foundation of Guangdong Province (no. 2018B030311020), the Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program (2017BT01Y036), Guangdong Basic and Applied Basic Research Foundation-Regional Joint Fund (Youth Fund Project, no. 2020A1515110415).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>We thanked the High Performance Public Computing Service Platform of Jinan University for the help of theoretical ECD calculations.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article including original UV, CD, IR, HRESIMS, 1D/2D NMR spectra can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2021.740421/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2021.740421/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>X.-H.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Structural Modifications of Matrine-Type Alkaloids</article-title>. <source>Mini. Rev. Med. Chem.</source> <volume>18</volume>, <fpage>730</fpage>&#x2013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.2174/1389557516666161104150334</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Matrine-Family Alkaloids: Versatile Precursors for Bioactive Modifications</article-title>. <source>Min. Rev. Med. Chem.</source> <volume>16</volume>, <fpage>431</fpage>&#x2013;<lpage>453</lpage>. <pub-id pub-id-type="doi">10.2174/1573406415666190507121744</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W. X.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Semi-Synthesis and Characterization of Some New Matrine Derivatives as Insecticidal Agents</article-title>. <source>Pest Manag. Sci.</source> <volume>76</volume>, <fpage>2711</fpage>&#x2013;<lpage>2719</lpage>. <pub-id pub-id-type="doi">10.1002/ps.5817</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Synthesis, Characterization and <italic>In Vitro</italic> Biological Evaluation of Two Matrine Derivatives</article-title>. <source>Sci. Rep.</source> <volume>8</volume>, <fpage>15686</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-33908-8</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>X. X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>R. Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q. X.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>X. J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>
<italic>Sophora Alopecuroides</italic> L.: An Ethnopharmacological, Phytochemical, and Pharmacological Review</article-title>. <source>J.&#x20;Ethnopharmacol.</source> <volume>248</volume>, <fpage>112172</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2019.112172</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>H. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Alopecuroides A&#x2013;E, Matrine-Type Alkaloid Dimers from the Aerial Parts of <italic>Sophora Alopecuroides</italic>
</article-title>. <source>J.&#x20;Nat. Prod.</source> <volume>82</volume>, <fpage>3227</fpage>&#x2013;<lpage>3232</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.8b01081</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G. C.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Quinolizidine Alkaloids from <italic>Sophora Tonkinensis</italic> and Their Anti-Inflammatory Activities</article-title>. <source>Fitoterapia</source> <volume>139</volume>, <fpage>104391</fpage>. <pub-id pub-id-type="doi">10.1016/j.fitote.2019.104391</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Semisynthesis of Some Matrine Ether Derivatives as Insecticidal Agents</article-title>. <source>Rsc Adv.</source> <volume>7</volume>, <fpage>15997</fpage>&#x2013;<lpage>16004</lpage>. <pub-id pub-id-type="doi">10.1039/c7ra00954b</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y. X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Traditional Uses, Phytochemistry, and Pharmacological Properties of <italic>Sophora Alopecuroides L</italic>
</article-title>. <source>Eur. J.&#x20;Inflamm.</source> <volume>14</volume>, <fpage>128</fpage>&#x2013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1177/1721727x16642779</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ouyang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Quinolizidine Alkaloids Derivatives from <italic>Sophora Alopecuroides</italic> Linn: Bioactivities, Structure-Activity Relationships and Preliminary Molecular Mechanisms</article-title>. <source>Eur. J.&#x20;Med. Chem.</source> <volume>188</volume>, <fpage>111972</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2019.111972</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z. N.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Sophaloseedlines A&#x2212;G: Diverse Matrine-Based Alkaloids from <italic>Sophora Alopecuroides</italic> with Potential Anti-Hepatitis B Virus Activities</article-title>. <source>Chin. J.&#x20;Chem.</source> <volume>39</volume>, <fpage>2555</fpage>&#x2013;<lpage>2562</lpage>. <pub-id pub-id-type="doi">10.1002/cjoc.202100279</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G. C.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Synthesis of Matrinic Amide Derivatives Containing 1,3,4-thiadiazole Scaffold as Insecticidal/acaricidal Agents</article-title>. <source>Bioorg. Chem.</source> <volume>81</volume>, <fpage>88</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2018.07.034</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Potential Mechanism Underlying the Effect of Matrine on COVID-19 Patients Revealed through Network Pharmacological Approaches and Molecular Docking Analysis</article-title>. <source>Arch. Physiol. Biochem.</source> <fpage>1</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1080/13813455.2020.1817944</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H. Q.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Comparative Analysis of Quinolizidine Alkaloids from Different Parts of <italic>Sophora Alopecuroides</italic> Seeds by UPLC&#x2013;MS/MS</article-title>. <source>J.&#x20;Pharmaceut. Biomed.</source> <volume>67</volume>, <fpage>16</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2012.04.024</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Hao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Evaluation of Biological Activities, and Exploration on Mechanism of Action of Matrine&#x2013;Cholesterol Derivatives</article-title>. <source>Bioorg. Chem.</source> <volume>94</volume>, <fpage>103439</fpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2019.103439</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B. Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>W. Y.</given-names>
</name>
<name>
<surname>Otsuki</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Higai</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Sacraoxides A&#x2013;G, Bioactive Cembranoids from Gum Resin of <italic>Boswellia Sacra</italic>
</article-title>. <source>Front. Chem.</source> <volume>9</volume>, <fpage>649287</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2021.649287</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L. J.</given-names>
</name>
<name>
<surname>Kuang</surname>
<given-names>G. K.</given-names>
</name>
<etal/>
</person-group> (<year>2018a</year>). <article-title>Matrine-Type Alkaloids from the Roots of <italic>Sophora Flavescens</italic> and Their Antiviral Activities against the Hepatitis B Virus</article-title>. <source>J.&#x20;Nat. Prod.</source> <volume>81</volume>, <fpage>2259</fpage>&#x2013;<lpage>2265</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.8b00576</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z. N.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>W. C.</given-names>
</name>
<etal/>
</person-group> (<year>2018b</year>). <article-title>Sophalines E-I, Five Quinolizidine-Based Alkaloids with Antiviral Activities against the Hepatitis B Virus from the Seeds of <italic>Sophora Alopecuroides</italic>
</article-title>. <source>Org. Lett.</source> <volume>20</volume>, <fpage>5942</fpage>&#x2013;<lpage>5946</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.8b02637</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Zhan</surname>
<given-names>L. Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G. Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. L.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Dimeric Matrine-Type Alkaloids from the Roots of <italic>Sophora Flavescens</italic> and Their Anti-Hepatitis B Virus Activities</article-title>. <source>J.&#x20;Org. Chem.</source> <volume>81</volume>, <fpage>6273</fpage>&#x2013;<lpage>6280</lpage>. <pub-id pub-id-type="doi">10.1021/acs.joc.6b00804</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y. B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X. L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z. N.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. L.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Four Matrine-Based Alkaloids with Antiviral Activities against HBV from the Seeds of <italic>Sophora Alopecuroides</italic>
</article-title>. <source>Org. Lett.</source> <volume>19</volume>, <fpage>424</fpage>&#x2013;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.6b03685</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zou</surname>
<given-names>J.&#x20;B.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>L. H.</given-names>
</name>
<name>
<surname>Yi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L. X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y. N.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Quinolizidine Alkaloids with Antiviral and Insecticidal Activities from the Seeds of <italic>Sophora Tonkinensis</italic> Gagnep</article-title>. <source>J.&#x20;Agr. Food Chem.</source> <volume>68</volume>, <fpage>15015</fpage>&#x2013;<lpage>15026</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.0c06032</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>